Gene gun-mediated dna vaccination induces antitumor immunity against human papillomavirus type 16 e7-expressing murine tumor metastases in the liver and lungs

feature-image

Play all audios:

Loading...

ABSTRACT DNA vaccination has emerged as an attractive approach for tumor immunotherapy. The aim of this study was to evaluate the potency of DNA vaccines in preventing and treating the liver


and lung metastases of a human papillomavirus-16 (HPV-16) E7-expressing murine tumor (TC-1). We used the gene gun method to vaccinate C57BL/6 mice intradermally with DNA vaccines containing


the HPV-16 E7 gene, the E7 gene linked to the sorting signals of the lysosome-associated membrane protein-1 (Sig/E7/ LAMP-1), or the ‘empty’ plasmid vector. The in vivo antitumor immunity


was analyzed in both tumor prevention and tumor regression experiments. In addition, cytotoxic T lymphocyte (CTL) assays, enzyme-linked immunospot assay and enzyme-linked immunoabsorbent


assay were used to assess the E7-specific T cell-mediated and humoral immunity. Mice vaccinated with Sig/E7/LAMP-1 DNA generated the strongest E7-specific CTL activities, the highest numbers


of E7-specific CD8+ cell precursors and the highest titers of E7-specific antibodies. While both E7 DNA and Sig/E7/LAMP-1 DNA generated potent antitumor immunity in the liver and lung


metastases models, the Sig/E7/LAMP-1 DNA was more potent under stringent conditions. DNA vaccination with E7-expressing plasmids was effective in controlling liver and lung metastases of an


E7-expressing murine tumor. Our data suggest that antigen-specific DNA vaccination can potentially be applied to control liver and lung metastases of tumors with defined tumor-specific


antigens. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to


this journal Receive 6 print issues and online access $259.00 per year only $43.17 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy


now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer


support SIMILAR CONTENT BEING VIEWED BY OTHERS COMBINATION IMMUNOTHERAPY WITH TWO ATTENUATED _LISTERIA_ STRAINS CARRYING SHUFFLED HPV-16 E6E7 PROTEIN CAUSES TUMOR REGRESSION IN A MOUSE


TUMOR MODEL Article Open access 28 June 2021 CHIMERIC ADENOVIRAL (AD5.F35) AND LISTERIA VECTOR PRIME-BOOST IMMUNIZATION IS SAFE AND EFFECTIVE FOR CANCER IMMUNOTHERAPY Article Open access 23


June 2022 CLINICAL TRIALS OF SELF-REPLICATING RNA-BASED CANCER VACCINES Article Open access 10 February 2023 REFERENCES * Chen CH, Wu TC . Experimental vaccine strategies for cancer


immunotherapy _J Biomed Sci_ 1998 5: 231–252 Article  CAS  PubMed  Google Scholar  * Sznol M, Holmlund J . Antigen-specific agents in develoment (review) _Semin Oncol_ 1997 24: 173–186 CAS 


PubMed  Google Scholar  * Jaffee EM, Pardoll DM . Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines _Methods_ 1997 12: 143–153 Article  CAS  PubMed


  Google Scholar  * Pardoll DM, Beckerleg AM . Exposing the immunology of naked DNA vaccines (review) _Immunity_ 1995 3: 165–169 Article  CAS  PubMed  Google Scholar  * Donnelly JJ, Ulmer


JB, Liu MA . DNA vaccines (review) _Life Sci_ 1997 60: 163–172 Article  CAS  PubMed  Google Scholar  * Robinson HL, Torres CA . DNA vaccines _Semin Immunol_ 1997 9: 271–283 Article  CAS 


PubMed  Google Scholar  * Lin K-Y _et al_. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen _Cancer Res_


1996 56: 21–26 CAS  PubMed  Google Scholar  * Ji H _et al_. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein _Int J


Cancer_ 1998 78: 41–45 Article  CAS  PubMed  Google Scholar  * Hanke T _et al_. Enhancement of MHC class-I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination


regime _Vaccine_ 1998 16: 439–445 Article  CAS  PubMed  Google Scholar  * Henriksen E . The lymphatic spread of carcinoma of the cervix and of the body of the uterus: a study of 420


necropsies _Am J Obstet Gynecol_ 1949 58: 924–942 Article  CAS  PubMed  Google Scholar  * Gilboa E . Murine models for cancer immunotherapy using cytokine gene modified tumor vaccines. In:


Forni G, Foa R, Santoni A, Frati L (eds) _Cytokine-induced Tumor Immunogeneity_ Academic Press: London 1994 130–143 Google Scholar  * Melief CJ, Kast WM . T-cell immunotherapy of tumors by


adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes _Immunol Rev_ 1995 145: 167–177 Article  CAS  PubMed  Google Scholar  * Murali-Krishna K _et


al_. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection _Immunity_ 1998 8: 177–187 Article  CAS  PubMed  Google Scholar  * Conry RM _et al_.


A carcinoembryonic antigen polynucleotide vaccine has _in vivo_ antitumor activity _Gene Therapy_ 1995 2: 59–65 CAS  PubMed  Google Scholar  * Syrengelas AD, Chen TT, Levy R . DNA


immunization induces protective immunity against B-cell lymphoma _Nature Med_ 1996 2: 1038–1041 Article  CAS  PubMed  Google Scholar  * Bright RK _et al_. Protection against a lethal


challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen _Cancer Res_ 1996 56: 1126–1130 CAS  PubMed  Google Scholar  * Schirmbeck R, Bohm W,


Reimann J . DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors _J Immunol_ 1996 157: 3550–3558 CAS 


PubMed  Google Scholar  * Rosato A _et al_. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A _Hum Gene Ther_


1997 8: 1451–1458 Article  CAS  PubMed  Google Scholar  * Geissler M _et al_. Genetic immunization with the free human chorionic gonadotropin beta subunit elicits cytotoxic T lymphocyte


responses and protects against tumor formation in mice _Lab Invest_ 1997 76: 859–871 CAS  PubMed  Google Scholar  * Schreurs MW _et al_. Genetic vaccination against the melanocyte


lineage-specific antigen gp100 induces cytotoxic T lyphocyte-mediated tumor protection _Cancer Res_ 1998 58: 2509–2514 CAS  PubMed  Google Scholar  * Chen Y _et al_. DNA vaccines encoding


full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors _Cancer Res_ 1998 58: 1965–1971 CAS  PubMed  Google Scholar  * Iwasaki A, Barber BH . Induction


by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor _Cancer Immunol Immunother_ 1998 45: 273–279 Article  CAS  PubMed 


Google Scholar  * Ciernik IF, Berzofsky JA, Carbone DP . Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes _J Immunol_ 1996 156:


2369–2375 CAS  PubMed  Google Scholar  * Irvine KR _et al_. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases _J Immunol_ 1996 156:


238–245 CAS  PubMed  Google Scholar  * Ross HM _et al_. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization _Clin Cancer Res_ 1997 3: 2191–2196 CAS 


PubMed  Google Scholar  * Ulmer JB _et al_. Heterologous protection against influenza by injection of DNA encoding a viral protein _Science_ 1993 259: 1745–1749 Article  CAS  PubMed  Google


Scholar  * Sparwasser T _et al_. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells _Eur J Immunol_ 1998 28: 2045–2054


Article  CAS  PubMed  Google Scholar  * Cohen AD, Boyer JD, Weiner DB . Modulating the immune response to genetic immunization _FASEB J_ 1998 12: 1611–1626 Article  CAS  PubMed  Google


Scholar  * Condon C _et al_. DNA-based immunization by _in vivo_ transfection of dendritic cells _Nature Med_ 1996 2: 1122–1128 Article  CAS  PubMed  Google Scholar  * Iwasaki A _et al_. The


dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites _J Immunol_ 1997 159: 11–14 CAS  PubMed  Google Scholar  * Porgador A _et


al_. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ cells after gene gun immunization _J Exp Med_ 1998 188: 1075–1082 Article  CAS  PubMed  PubMed


Central  Google Scholar  * Klinman DM _et al_. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory _J Immunol_ 1998 160: 2388–2392


CAS  PubMed  Google Scholar  * Wu TC _et al_. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens _Proc Natl Acad Sci USA_ 1995 92:


11671–11675 Article  CAS  PubMed  PubMed Central  Google Scholar  * Ruff AL _et al_. The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome


membrane protein trafficking pathway _J Biol Chem_ 1997 272: 8671–8678 Article  CAS  PubMed  Google Scholar  * Boyle JS, Koniaras C, Lew AM . Influence of cellular location of expressed


antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization _Int Immunol_ 1997


9: 1897–1906 Article  CAS  PubMed  Google Scholar  * Choi AH _et al_. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but


fails to protect mice against challenge _Virology_ 1998 250: 230–240 Article  CAS  PubMed  Google Scholar  * Akbari O _et al_. DNA vaccination: transfection and activation of dendritic cells


as key events for immunity _J Exp Med_ 1999 189: 169–178 Article  CAS  PubMed  PubMed Central  Google Scholar  * Sigal LJ _et al_. Cytotoxic T-cell immunity to virus-infected


non-haematopoietic cells requires presentation of exogenous antigen _Nature_ 1999 398: 78–80 Article  Google Scholar  * Bennett SR _et al_. Induction of a CD8+ cytotoxic T lymphocyte


response by cross-priming requires cognate CD4+ T cell help _J Exp Med_ 1997 186: 65–70 Article  CAS  PubMed  PubMed Central  Google Scholar  * Feltkamp MC _et al_. Vaccination with


cytotoxic T lymphcoyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells _Eur J Immunol_ 1993 23: 2242–2249 Article  CAS  PubMed 


Google Scholar  * Miyahira Y _et al_. Quantification of antigen specific CD8+ T cells using an ELISPOT assay _J Immunol Meth_ 1995 181: 45–54 Article  CAS  Google Scholar  * McCutcheon M _et


al_. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes _J Immunol Meth_ 1997 210: 149–166 Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We would


like to thank Drs Tian-Li Wang, Chien-Fu Hung and Robert J Kurman for helpful discussions. We would also like to thank Haiyan Chen for superb technical help and Morris Ling for preparation


of the manuscript. This work was supported by NIH 5 po1 34582-01, U19 CA72108-02, RO1 CA72631-01 and the Richard W TeLinde endowment. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department


of Oncology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA C-H Chen, D M Pardoll & T-C Wu * Department of Internal Medicine, National Taiwan University Hospital,


National Taiwan University, Taipei, Taiwan C-H Chen * Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA H Ji & T-C Wu * Department of Surgery, The


Johns Hopkins Medical Institutions, Baltimore, Maryland, USA K W Suh & M A Choti * Department of Surgery, School of Medicine, Ajou University, South Korea K W Suh * Department of


Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA T-C Wu * Department of Molecular Microbiology and Immunology, The Johns Hopkins Medical


Institutions, Baltimore, Maryland, USA T-C Wu Authors * C-H Chen View author publications You can also search for this author inPubMed Google Scholar * H Ji View author publications You can


also search for this author inPubMed Google Scholar * K W Suh View author publications You can also search for this author inPubMed Google Scholar * M A Choti View author publications You


can also search for this author inPubMed Google Scholar * D M Pardoll View author publications You can also search for this author inPubMed Google Scholar * T-C Wu View author publications


You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Chen, CH., Ji, H., Suh, K. _et al._ Gene


gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. _Gene Ther_ 6, 1972–1981 (1999).


https://doi.org/10.1038/sj.gt.3301067 Download citation * Received: 28 June 1999 * Accepted: 31 August 1999 * Published: 05 January 2000 * Issue Date: 01 December 1999 * DOI:


https://doi.org/10.1038/sj.gt.3301067 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * DNA vaccine * metastasis * human papillomaviruses *


LAMP-1 * antitumor * E7